User:Allie Pointer/Pointer Sandbox 1

From Proteopedia

proteopedia linkproteopedia link

Interleukin-12

spinqualitylabelsall models Caption for this structure Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image This is a default text for your page Allie Pointer/Pointer Sandbox 1. Click above on edit this page to modify. Be careful with the < and > signs. You may include any references to papers as in: the use of JSmol in Proteopedia [1] or to the article describing Jmol [2] to the rescue. Contents 1 Notes for making page 2 Function 3 Random New Subsection(I can change/add these as I want) 4 Disease 5 Relevance 6 Structural highlights Notes for making page Try to figure out how to get image to show up first thing when opening page Il-12 also known as This is to figure out how to include references in actual writing [3] If you include reference in writing it is going to double show up in reference list Reference shows up have to be above the (arrow references arrow) Function Random New Subsection(I can change/add these as I want) Disease Relevance Structural highlights This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.

References

^{[4] [5]}

1. ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
2. ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
3. ↑ Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014 May;63(5):419-35. doi: 10.1007/s00262-014-1523-1., Epub 2014 Feb 11. PMID:24514955 doi:http://dx.doi.org/10.1007/s00262-014-1523-1
4. ↑ Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014 May;63(5):419-35. doi: 10.1007/s00262-014-1523-1., Epub 2014 Feb 11. PMID:24514955 doi:http://dx.doi.org/10.1007/s00262-014-1523-1
5. ↑ Yoon C, Johnston SC, Tang J, Stahl M, Tobin JF, Somers WS. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J. 2000 Jul 17;19(14):3530-41. PMID:10899108 doi:http://dx.doi.org/10.1093/emboj/19.14.3530